XTL Biopharmaceuticals Ltd.

Contributing Author

Recent Articles by XTL Biopharmaceuticals Ltd.

Jan-29	XTL Update on Recent Developments XTLB -5.81% GlobeNewswire
Jan-23	XTL Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders' Equity Deficiency XTLB -10.08% XTLB GlobeNewswire
Jan-13	XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership XTLB +56.66% GlobeNewswire
Dec-24	XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency XTLB -5.74% XTLB GlobeNewswire